Delivery Order SPE2DB22D9239-SPE2DB25FDL74
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $87,418.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a continuation of the companies' established partnership. The award was made without a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order valued at $87,418.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xenpozyme 20 mg vials. The contract was awarded on September 4, 2025, with an ultimate completion date of September 25, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $87,418.08 by the Defense Logistics Agency on July 30, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, valued at $87,418.08, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 6, 2024. DMS Pharmaceutical Group is a key supplier for the DLA, holding a $499,999,999 Indefinite Delivery Contract to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS and has an ultimate completion date of April 15, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which is valued at up...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XENPOZYME 20 mg vials. The $109,272.60 contract has a completion date of March 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, particularly the Department of Veterans Affairs and Department of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $37,693.80 by the Defense Logistics Agency's Medical Supply Chain division on August 13, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, carries no set-aside designation and represents performance at the contractor's Park Ridge location. The award leverages DMS Pharmaceutical Group's position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,780.55 by the Defense Logistics Agency's Medical Supply Chain division on August 19, 2025. This delivery order, with an ultimate completion date of September 17, 2025, carries no set-aside designation and represents a specific pharmaceutical supply requirement to be delivered to Park Ridge, Illinois. The award is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $23,866.20 by the Defense Logistics Agency's Medical Supply Chain division on July 30, 2025. This delivery order, with an ultimate completion date of July 31, 2025, represents a single issuance under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL74Delivery Order
The Defense Logistics Agency awarded a $87.4K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xenpozyme 20 mg vials. The contract is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and was awarded on September 10, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status. The place of performance is the vendor's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at approximately $500 million and valid through November 2026. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's established federal contracting portfolio demonstrates consistent success in providing specialized pharmaceutical products, including oncology treatments, vaccines, and specialty medications essential to military health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $87.4k | 9/10/25 |